Impaired vitamin D signaling is associated with frequent development of renal cell tumor in end-stage kidney disease

J Docs, D Banyai, T Flasko, A Szanto… - Anticancer …, 2020 - ar.iiarjournals.org
Background/Aim: End-stage kidney disease is characterized by chronic inflammation and
frequent development of cancer. The level of circulating vitamin D is generally low in …

Vitamin D hydroxylases CYP 2R1, CYP 27B1 and CYP 24A1 in renal cell carcinoma

A Urbschat, P Paulus… - European journal of …, 2013 - Wiley Online Library
Background There is increasing evidence that vitamin D metabolites influence
carcinogenesis. Besides its role in mineral homoeostasis, calcitriol, the active metabolite of …

Expression of the vitamin D receptor, 25-hydroxylases, 1α-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer

MB Jensen, CB Andersen, JE Nielsen, P Bagi… - The Journal of steroid …, 2010 - Elsevier
BACKGROUND: The vitamin D receptor (VDR), CYP27B1 and CYP24A1 are expressed in
the human kidney, but the segmental expression of the 25-hydroxylases is unknown. A …

[HTML][HTML] Editorial Comment: Dietary and circulating vitamin D and risk of renal cell carcinoma: a meta-analysis of observational studies

BM Gregorio - International braz j urol, 2021 - SciELO Brasil
Doctor Wu and colleagues from China conducted an important meta-analysis of
observational studies on dietary and circulating levels of vitamin D and its relationship to the …

[HTML][HTML] Expression of vitamin D receptor (VDR) positively correlates with survival of urothelial bladder cancer patients

W Jóźwicki, AA Brożyna, J Siekiera… - International journal of …, 2015 - mdpi.com
Vitamin D3 shows tumoristatic and anticancer effects by acting through the vitamin D
receptor (VDR), while hydroxylation of 25-hydroxyvitamin D3 at position 1α by CYP27B1 is …

Prevention of renal cell carcinoma by active vitamin D3

T Fujioka, Y Suzuki, T Okamoto, N Mastushita… - World journal of …, 2000 - Springer
A bstract We studied the serum levels of 1, 25-dihydroxyvitamin D [1, 25 (OH) 2 D (Vit D)] in
patients with renal cell carcinoma (RCC) and the influence of 1, 25 (OH) 2 D 3 (Vit D 3) on …

[HTML][HTML] Dysregulation of renal vitamin D metabolism in the uremic rat

CF Helvig, D Cuerrier, CM Hosfield, B Ireland… - Kidney international, 2010 - Elsevier
The progressive decline in kidney function and concomitant loss of renal 1α-hydroxylase
(CYP27B1) in chronic kidney disease (CKD) are associated with a gradual loss of circulating …

Vitamin D metabolism and signaling in human hepatocellular carcinoma and surrounding non-tumorous liver

E Horváth, B Balla, J Kósa, PA Lakatos, Á Lazáry… - Orvosi …, 2016 - europepmc.org
Aim We examined mRNA and protein expression differences in 1, 25-Dihydroxy vitamin D 3-
inactivating CYP24A1, mRNA of activating CYP27B1 enzymes, and that of VDR between …

Vitamin D and Renal Cancer

J Cannell - yippy.green
Vitamin D and Renal Cancer yippy GREEN yippy GREEN Info English English Deutsch
Contact Contact Plus de résultats Buy Now vitamin d vitamin Vitamin D and Renal Cancer …

Circulating 25-Hydroxyvitamin D3 and Survival after Diagnosis with Kidney Cancer

DC Muller, G Scelo, D Zaridze, V Janout… - … Biomarkers & Prevention, 2015 - AACR
Prospective cohort studies have provided some evidence that circulating vitamin D is
associated with risk of, and survival from, renal cell carcinoma (RCC), but it is unclear …